Markedly elevated serum level of presepsin in agranulocytosis with hematologic malignancy: A potential prognostic factor in a single-institution retrospective study after granulocyte transfusion
Presepsin is a biomarker that can be assessed in patients undergoing GTX for agranulocytosis. A clinically significant increase in P-SEP levels before GTX may indicate ineffective GTX and an unfavorable prognosis.
Authors
- Kazuhiro Ikeuchi
- Naomi Asano
- Noboru Asada (ORCID: https://orcid.org/0000-0001-7322-5460)
- Keisuke Seike (ORCID: https://orcid.org/0000-0002-3484-0265)
- Wataru Kitamura (ORCID: https://orcid.org/0000-0002-8021-4732)
- Fumio Otsuka (ORCID: https://orcid.org/0000-0001-7014-9095)
- Takumi Kondo (ORCID: https://orcid.org/0000-0002-6395-7913)
- Daisuke Ennishi (ORCID: https://orcid.org/0000-0003-4788-2103)
- Akira Yamamoto (ORCID: https://orcid.org/0000-0001-7574-6446)
- Takuya Fukumi
- Hiroki Kobayashi (ORCID: https://orcid.org/0000-0001-7892-4674)
- Nobuharu Fujii
- Yoshinobu Maeda (ORCID: https://orcid.org/0009-0004-0051-0075)
- Keiko Fujii (ORCID: https://orcid.org/0009-0005-7614-2448)
- Ken-ichi Matsuoka
- Hideaki Fujiwara (ORCID: https://orcid.org/0000-0002-0734-9315)
Institutions
- Okayama University (JP)
- Okayama University Hospital (JP)
Publication Details
- Journal
- Laboratory Medicine
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1093/labmed/lmae118
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00